Hemostatic and hematological abnormalities in gain‐of‐function fps/fes transgenic mice are associated with the angiogenic phenotype

Sangrar, Waheed; Senis, Yotis A.; Samis, John A.; Gao, Yan; Richardson, M.; Lee, D H; Greer, Peter A.

doi:10.1111/j.1538-7836.2004.00956.x

Cited by 3 publications

(1 citation statement)

References 60 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Furthermore, FES knockout (FES -/-) mice demonstrate dysregulation of signal transducer and activator of transcription 3 (STAT3) (13), which plays a vital role in the pathophysiology of sepsis by initiating endothelial dysfunction, vasoplegia, coagulopathy, and multi-organ failure (14,15). FES may also contribute to thrombin formation (16), which is known to contribute to hypercoagulation during the early inflammatory stage of sepsis (17).…”

Section: Introductionmentioning

confidence: 99%

Establishing the role of the FES tyrosine kinase in the pathogenesis, pathophysiology, and severity of sepsis and its outcomes

et al. 2023

View full text Add to dashboard Cite

IntroductionSepsis is a result of initial over-activation of the immune system in response to an infection or trauma that results in reduced blood flow and life-threatening end-organ damage, followed by suppression of the immune system that prevents proper clearance of the infection or trauma. Because of this, therapies that not only limit the activation of the immune system early on, but also improve blood flow to crucial organs and reactivate the immune system in late-stage sepsis, may be effective treatments. The tyrosine kinase FES may fulfill this role. FES is present in immune cells and serves to limit immune system activation. We hypothesize that by enhancing FES in early sepsis and inhibiting its effects in late sepsis, the severity and outcome of septic illness can be improved.Methods and analysisIn vitro and in vivo modeling will be performed to determine the degree of inflammatory signaling, cytokine production, and neutrophil extracellular trap (NET) formation that occurs in wild-type (WT) and FES knockout (FES-/-) mice. Clinically available treatments known to enhance or inhibit FES expression (lorlatinib and decitabine, respectively), will be used to explore the impact of early vs. late FES modulation on outcomes in WT mice. Bioinformatic analysis will be performed to examine FES expression levels in RNA transcriptomic data from sepsis patient cohorts, and correlate FES expression data with clinical outcomes (diagnosis of sepsis, illness severity, hospital length-of-stay).Ethics and disseminationEthics approval pending from the Queen’s University Health Sciences & Affiliated Teaching Hospitals Research Ethics Board. Results will be disseminated through scientific publications and through lay summaries to patients and families.

show abstract

Section: Introductionmentioning

confidence: 99%